IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 40 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,192,000 | -24.3% | 2,415,999 | +5.4% | 0.00% | – |
| Q1 2018 | $4,215,000 | -3.8% | 2,292,160 | +10.3% | 0.00% | – |
| Q4 2017 | $4,382,000 | +4.4% | 2,077,266 | +10.4% | 0.00% | – |
| Q3 2017 | $4,196,000 | +36.5% | 1,880,855 | +5.2% | 0.00% | – |
| Q2 2017 | $3,075,000 | -21.4% | 1,787,852 | +13.0% | 0.00% | – |
| Q1 2017 | $3,912,000 | +67.9% | 1,582,635 | +1.9% | 0.00% | – |
| Q4 2016 | $2,330,000 | -34.5% | 1,553,323 | +11.7% | 0.00% | – |
| Q3 2016 | $3,559,000 | +74.4% | 1,391,150 | +4.4% | 0.00% | – |
| Q2 2016 | $2,041,000 | -14.2% | 1,332,201 | +10.7% | 0.00% | – |
| Q1 2016 | $2,380,000 | -36.0% | 1,203,168 | -0.0% | 0.00% | – |
| Q4 2015 | $3,717,000 | -6.8% | 1,203,422 | +1.0% | 0.00% | – |
| Q3 2015 | $3,990,000 | -87.2% | 1,191,342 | -85.8% | 0.00% | -100.0% |
| Q2 2015 | $31,091,000 | +29.5% | 8,380,900 | +29.5% | 0.00% | +50.0% |
| Q1 2015 | $24,007,000 | +531.3% | 6,471,069 | +649.9% | 0.00% | – |
| Q4 2014 | $3,803,000 | +121.6% | 862,899 | +14.9% | 0.00% | – |
| Q3 2014 | $1,716,000 | +0.2% | 750,724 | +27.1% | 0.00% | – |
| Q2 2014 | $1,712,000 | +641.1% | 590,691 | +945.5% | 0.00% | – |
| Q1 2014 | $231,000 | +87.8% | 56,500 | +37.5% | 0.00% | – |
| Q4 2013 | $123,000 | +324.1% | 41,100 | +144.6% | 0.00% | – |
| Q3 2013 | $29,000 | +163.6% | 16,800 | 0.0% | 0.00% | – |
| Q2 2013 | $11,000 | – | 16,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|